[HTML][HTML] Clinical implications of basic research: exploring the transformative potential of spatial'omics in uro-oncology

S Figiel, A Bates, DA Braun, R Eapen, M Eckstein… - European Urology, 2024 - Elsevier
New spatial molecular technologies are poised to transform our understanding and
treatment of urological cancers. By mapping the spatial molecular architecture of tumours …

Summary of the clinical practice guidelines for upper tract urothelial carcinoma 2023 by the Japanese Urological Association

K Mori, S Hatakeyama, H Enokida… - … Journal of Urology, 2024 - Wiley Online Library
This article is an English translation of the Clinical Practice Guidelines for Upper Tract
Urothelial Carcinoma (2nd edition) published in June 2023. The Japanese Urological …

[HTML][HTML] Protodioscin inhibits bladder cancer cell migration and growth, and promotes apoptosis through activating JNK and p38 signaling pathways

YR Chen, SC Wang, SP Huang, CC Su, PL Liu… - Biomedicine & …, 2022 - Elsevier
Bladder cancer is one of the most common malignancies of the male genitourinary urinary
system. Protodioscin is a steroidal saponin with anti-cancer effects on several types of …

Standardized care pathways for patients with suspected urinary bladder cancer: the Swedish experience

S Abuhasanein, S Jahnson, F Aljabery… - … journal of urology, 2022 - Taylor & Francis
Objectives To compare time intervals to diagnosis and treatment, tumor characteristics, and
management in patients with primary urinary bladder cancer, diagnosed before and after the …

Sensitivity of virtual non-contrast dual-energy CT urogram for detection of urinary calculi: a systematic review and meta-analysis

K McCoombe, K Dobeli, S Meikle, S Llewellyn… - European …, 2022 - Springer
Objective To determine the sensitivity of dual-energy (DE) virtual non-contrast computed
tomography (vNCT), generated from the excretory phase of a CT urogram, compared to true …

Diagnostic imaging in the evaluation of asymptomatic microhematuria: systematic review and meta-analysis

JI Taylor, LH Souter, DA Barocas, SA Boorjian… - The Journal of …, 2023 - auajournals.org
Purpose: Microhematuria is a highly prevalent condition with a low associated risk of
urothelial and upper tract malignancy. The AUA Guidelines recently changed …

A urine-based genomic assay improves risk stratification for patients with high-risk hematuria stratified according to the American Urological Association guidelines

JJ de Jong, OM Pijpers, KEM van Kessel… - European Urology …, 2023 - Elsevier
Background According to the recent American Urological Association (AUA) guideline on
hematuria, patients are stratified into groups with low, intermediate, and high risk of …

Computed tomography urography with corticomedullary phase can exclude urinary bladder cancer with high accuracy

S Abuhasanein, C Hansen, D Vojinovic, S Jahnson… - BMC urology, 2022 - Springer
Background To evaluate the diagnostic accuracy of computed tomography-urography (CTU)
to rule out urinary bladder cancer (UBC) and whether patients thereby could omit …

Potential of an mRNA-Based Urine Assay (Xpert® Bladder Cancer Detection1) in Hematuria Patients - Results from a Cohort Study

C Schmitz-Dräger, PJ Goebell, E Paxinos… - Bladder …, 2024 - journals.sagepub.com
BACKGROUND AND OBJECTIVE: Assessment of patients with hematuria (aH) remains a
challenge in urological practice, balancing the benefits of diagnosing a potentially …

Toward the deimplementation of computed tomography urogram for patients with low-to intermediate-risk microscopic hematuria: a mixed-method study of factors …

SA Birken, R Matulewicz, R Pathak, CR Wagi… - Urology …, 2023 - auajournals.org
Introduction: Citing high costs, limited diagnostic benefit, and ionizing radiation–associated
risk from CT urogram, in 2020 the AUA revised its guidelines from recommending CT …